Treatment with interferon-α2b speeds up recovery of COVID-19 patients in exploratory study

An exploratory study on a cohort of 77 confirmed COVID-19 cases in Wuhan showed treatment with the antiviral IFN-α2b reduced viral clearance time and reduced circulatory levels of inflammatory markers IL-6 and CRP. The research team followed on from previous successes when they demonstrated interferon therapy had therapeutic benefits during the SARS outbreak of 2002 and 2003.